Neurons are highly polarized cells, possessing two morphologically and functionally distinct domains, axons and dendrites^[@R1],[@R2]^. In developing neurons, membrane trafficking is essential for delivering diverse organelles and molecules that are required for elongation and guidance of the growing axon or dendrite processes^[@R3],[@R4],[@R5]^. Especially bi-directional endosomal trafficking between cell body and neurite termini is crucial to respond to continuously changing surrounding environments; endosomal trafficking regulates the number and activity of cell-surface molecules at the neurite termini in time and space^[@R6]^. For example, brain derived neurotrophic factor (BDNF) driven Trk receptor endocytosis at growth cone affects axon growth^[@R7],[@R8]^. Asymmetric clathrin-mediated endocytosis of adhesion receptors such as integrins is required for repulsive growth cone guidance^[@R9]^.

Among vesicular structures in endocytic pathway, early endosomes are essential for cell signalling, serving both as signalling centres and as sorting centres to degrade or recycle cargoes^[@R10],[@R11]^. The organization of early endosomes consists of three steps; endocytosis, clustering, and fusion. Internalized small early endosomes are clustered and then undergo fusion to become matured early endosomes. Rab5 is a key regulator for ligand sequestration at plasma membrane and repetitive fusion of internalized early endosomes by recruiting its effectors such as VPS34/p150, EEA1, Rabaptin-5, and Rabenosyn-5 (Rbsn-5)^[@R12]-[@R17]^. In addition, the dynein-dependent transport of small early endosomes from the periphery to the cell centre is important for clustering them^[@R18],[@R19]^. Recently, the essential roles of endocytosis in axon elongation of mouse sympathetic neurons^[@R7]^ and endocytosis and endosomal trafficking in the dendrite arborization of *Drosophila* dendritic arborization (da) sensory neurons^[@R20],[@R21]^ were reported. However, the physiological significance of clustering of early endosomes and the molecular link between the transport/clustering and Rab5 activity are largely unknown.

We here performed a forward genetic mosaic screen to identify genes for their cell-autonomous functions in dendrite and axonal development, and identified an evolutionarily conserved protein, [Str]{.ul}iatin-[i]{.ul}nteracting [p]{.ul}rotein (Strip), that works as a molecular linker between retrograde transport and Rab5 activity in early endosome organization. Strip and its orthologs were reported to be a component of Striatin-interacting phosphatase and kinase (STRIPAK) complex^[@R22]-[@R24]^, however, the function of Strip has not been reported yet, to our knowledge. Interestingly, we found that Strip forms the protein complex with both Glued, the ortholog of mammalian p150^Glued^, and Sprint, the ortholog of RIN-1. Glued is an essential component of the dynactin complex and regulates the initiation of retrograde transport on microtubule^[@R25]-[@R29]^ and Sprint is supposed to be a guanine nucleotide exchange factor (GEF) for Rab5^[@R30],\ [@R31]^. We found that Strip affects the transport of early endosomes by forming complex with Glued in developing neurons. Furthermore, clustering of early endosomes is defective in *strip* knockdown *Drosophila* S2 cells and HeLa cells; early endosomes become smaller and scattered as reported in dynein-inhibited HeLa cells^[@R18]^. Moreover, similar with other GEFs, Sprint and Strip have a higher affinity for guanosine diphosphate (GDP)-bound forms of Rab5 than for guanosine triphosphate (GTP)-bound form. In addition, Strip seems to stabilize protein level of Sprint. Finally, the expression of constitutively active form of Rab5 in *strip* mutant neurons suppresses the axon elongation defect. These data demonstrate that Strip coordinates dynein-dependent transport and Rab5 activation at the clustering and fusion of early endosomes, which are required for axon elongation.

Results {#S1}
=======

*strip^dogi^* PNs show defects in neuronal morphogenesis {#S2}
--------------------------------------------------------

*Drosophila* olfactory projection neurons (PNs) ([Fig. 1a](#F1){ref-type="fig"}), which are analogous to vertebrate mitral/tufted cells, provide an excellent model system for studying the molecular mechanisms of neuronal morphogenesis. Neuronal targeting and branching patterns of PNs are genetically defined^[@R32]-[@R34]^, and the mosaic analysis with a repressible cell marker (MARCM) method allows us to manipulate the genotype of a single PN (single-cell clone) or of a group of PNs that share the same lineage (neuroblast clone) and are positively labelled *in vivo*^[@R35]^. We performed a MARCM-based forward genetic screen of PNs to identify the genes essential for neuronal morphogenesis^[@R36]^, and isolated a mutant *[do]{.ul}ubled [g]{.ul}lomerul[i]{.ul}* (*dogi*). As we will mention below, the causal gene of *dogi* mutant is *strip* gene, thus we name this mutant allele *strip^dogi^* hereafter. Wild-type PN axons target two higher olfactory centres, the mushroom body and the lateral horn, while dendrites target specific glomeruli in the antennal lobe, the first olfactory centre consisting of approximately 50 glomeruli^[@R32],\ [@R37],\ [@R38]^ ([Fig. 1a,b](#F1){ref-type="fig"}). In neuroblast clones homozygous for *strip^dogi^*, neuronal guidance and targeting were severely defective, including ectopic innervation to the contralateral antennal lobe ([Fig 1d](#F1){ref-type="fig"}, dotted circle) or the subesophageal ganglion (SOG) ([Fig. 1d](#F1){ref-type="fig"}, arrowhead), which was never observed in wild-type neuroblast clones ([Fig. 1c](#F1){ref-type="fig"}).

To examine PN morphologies at a higher resolution, we generated single-cell clones homozygous for *strip^dogi^* (hereafter we call this single neuron as *strip^dogi^* PN). PNs that target a single glomerulus are categorized into roughly 50 classes, each with stereotyped dendrite and axon branching patterns^[@R32],[@R37],[@R38]^. In the wild-type DL1 PN, dendrites targeted the posterior, dorsolateral glomerulus DL1 and arborized within the DL1 glomerulus ([Fig. 1b,g](#F1){ref-type="fig"}), while the axon exhibited stereotypical L-shape branching in the lateral horn ([Fig. 1b,k](#F1){ref-type="fig"}). In the *strip^dogi^* DL1 PN, both axons and dendrites were defective. Unlike wild-type PNs, in which the dendrite shaft is generated by one branch that forms off the main branch and never branches further, *strip^dogi^* PN dendrites had an additional branch appearing from the proximal side of the dendrite shaft (magnified image in [Fig. 2f](#F2){ref-type="fig"} arrowhead, penetrance of additional branch: 35.3%, n = 24/68), resulting in dendrite targeting of two glomeruli rather than a single glomerulus ([Fig. 1h](#F1){ref-type="fig"}). The axons of *strip^dogi^* DL1 PNs did not elongate or form L-shaped branches within the lateral horn ([Fig. 1l](#F1){ref-type="fig"}, penetrance of short axon: 98.2%, n = 56/57).

Strip is required for PN morphogenesis {#S3}
--------------------------------------

To identify the causal gene for these *strip^dogi^* PN phenotypes, we performed meiotic recombination mapping using single nucleotide polymorphisms (SNPs)^[@R39]^ and P-elements^[@R40]^; this placed the *strip^dogi^* mutation in an approximately 28-kb region of 63D1 (see Methods for details). Within this region, we generated a small deletion allele, *Df(tc-1*), which lacked 7 kb of the genomic region containing *strip* (*CG11526*), *CG42456, CG12016*, and *CG12077* ([Fig. 1o](#F1){ref-type="fig"}). The MARCM *Df(tc-1)* clones exhibited defects in axon elongation, similar to those seen in *strip^dogi^* PNs ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}), and also in dendrite branching ([Supplementary Fig. 1b,c](#SD1){ref-type="supplementary-material"} arrowheads), which was observed in some *strip^dogi^* PNs ([Fig. 2e,f](#F2){ref-type="fig"} arrowhead). Next, we generated a short hairpin RNA against *strip* (*shRNA-strip*) to knock down *strip* expression; the expression of *shRNA-strip* in wild-type DL1 PN recapitulated the dendrite branching and axon elongation defects seen in *strip^dogi^* PNs ([Supplementary Fig. 1d--f](#SD1){ref-type="supplementary-material"}; see [Supplementary Fig. 1g--j](#SD1){ref-type="supplementary-material"} for the evaluation of *shRNA*-*strip*). Lastly, the expression of *strip* cDNA in *strip^dogi^* PN clones rescued all the *strip^dogi^* phenotypes ([Fig. 1e,i,m](#F1){ref-type="fig"}). These findings confirmed that *strip* is responsible for the *strip^dogi^* PN phenotypes, and is cell-autonomously required for neuronal morphogenesis, specifically for dendrite branching and axon elongation.

Strip protein is highly conserved from yeast to humans ([Supplementary Fig. 1k](#SD1){ref-type="supplementary-material"}), with 45.9% amino-acid identity and 81.4% similarity between *Drosophila* and human STRIP1, and known as a component of Striatin-interacting phosphatase and kinase (STRIPAK) complex^[@R22]-[@R24]^. However, Strip has no characterized functional domains and its function has not been studied yet. When the mouse orthologue of *strip, Strip1*^[@R41],[@R42]^ (MGI: 2443884) was expressed only in *strip^dogi^* PNs using the MARCM strategy, all the *strip^dogi^* phenotypes were rescued ([Fig. 1f,j,n](#F1){ref-type="fig"}), suggesting that the function of Strip is conserved between *Drosophila* and mammals. To characterize the Strip protein, we generated an antibody against Strip and confirmed its reliability by staining PNs homozygous for *Df(tc-1)* at 0 h after puparium formation (APF) ([Supplementary Fig. 1l--o](#SD1){ref-type="supplementary-material"}); immunostaining was not observed in *Df(tc1)*-homozygous cell bodies ([Supplementary Fig. 1o](#SD1){ref-type="supplementary-material"}). This result indicates that Strip is expressed in PNs during dendrite branching and axon elongation. Then, we used the Strip antibody for western blotting of embryo lysates from zygotic *strip^dogi^* and *Df(tc-1)* mutants, and found that the amount of Strip protein was significantly and similarly reduced in both lysates ([Fig. 1p](#F1){ref-type="fig"}). The remaining expression of Strip in zygotic *strip^dogi^* or *Df(tc-1)* mutants is probably due to the maternally-derived *strip* gene product. Thus, the *strip^dogi^* allele used for phenotypic analysis is a strong loss-of-function or null allele.

Strip interacts with Glued and Sprint {#S4}
-------------------------------------

To examine how Strip regulates dendrite branching and axon elongation, we performed a yeast two-hybrid screen using full-length Strip as bait and the *Drosophila* whole-embryo cDNA library as prey, and identified Glued (Gl) and Sprint (Spri) as the binding partners of Strip ([Fig. 2a](#F2){ref-type="fig"},[3a](#F3){ref-type="fig"}). Gl is a major component of the dynactin complex, which is a positive regulator of the microtubule (MT)-dependent retrograde motor, dynein, and regulates the initiation of retrograde transport^[@R25]-[@R29]^. Gl and its mouse ortholog, p150^Glued^, have an MT-binding domain, a dynein intermediate chain-binding domain, and an Arp1-associated domain ([Fig. 2a](#F2){ref-type="fig"}). The *Gl* cDNA fragment isolated from the yeast two-hybrid screen encoded 235 amino acids, from position 680 to 914, corresponding to the dynein- or Arp1-binding domain ([Fig. 2a](#F2){ref-type="fig"}). We confirmed this physical interaction by performing glutathione *S*-transferase (GST) pull-down and co-immunoprecipitation using *Drosophila* embryos and *Drosophila* S2 cell lysates ([Fig. 2b,c](#F2){ref-type="fig"}). The other binding partner of Strip, Spri is an ortholog of human RIN-1 and has a vacuolar protein sorting 9 (VPS9) domain that is crucial for its function as a GEF for the small GTPase protein, Rab5^[@R43]^ ([Fig. 3a](#F3){ref-type="fig"}). The *spri* cDNA fragment isolated from the yeast two-hybrid screen encoded 397 amino acids, from position 1404 to 1700, corresponding to the VPS9 domain ([Fig. 3a](#F3){ref-type="fig"}). We also confirmed this interaction by performing GST pull-down and co-immunoprecipitation using *Drosophila* embryos and *Drosophila* S2 cell lysates ([Fig. 3b--d](#F3){ref-type="fig"}).

We next examined the genetic interactions between *strip, Gl*, and *spri. Gl^1^* (dominant negative form of *Gl*) DL1 PNs ([Fig. 2g--i](#F2){ref-type="fig"}) or PNs expressing the *shRNA-spri* ([Fig. 3e--g](#F3){ref-type="fig"}) did not exhibit obvious defects in axon elongation ([Fig. 2g](#F2){ref-type="fig"} and [3e](#F3){ref-type="fig"}) or dendrite branching ([Fig. 2h,i](#F2){ref-type="fig"} arrowhead, [3f,g](#F3){ref-type="fig"}). Interestingly, axon elongation or dendrite branching phenotypes of *strip^dogi^* DL1 PNs ([Fig. 2d--f](#F2){ref-type="fig"}) became more severe by adding *Gl^1^* (double mutant clones for *strip^dogi^* and *Gl^1^*, [Fig. 2j--m](#F2){ref-type="fig"}) or expressing the *shRNA-spri* ([Fig. 3h--k](#F3){ref-type="fig"}). In both cases, we observed an extremely short axon phenotype, i.e., the axon did not exit the antennal lobe ([Fig. 2m](#F2){ref-type="fig"} (penetrance of extremely short axon: 15.6%, n = 5/32) and 3k (penetrance of extremely short axon: 13.0%, n = 3/23)), which was never observed in *strip^dogi^* DL1 PNs (penetrance of extremely short axon: 0%, n= 0 /68). We also found an obvious genetic interaction between *strip* and *Gl* in the rough-eye phenotype, in which Gl is known to be involved^[@R44]^ ([Supplementary Fig. 2a--d](#SD1){ref-type="supplementary-material"}). These biochemical and genetic data suggest that Strip functions with Gl and Spri in dendrite branching and axon elongation. Since *strip^dogi^, Gl^1^* PNs (double mutant clones) and *strip^dogi^* PNs expressing *shRNA-spri* exhibit the similar "extremely short axon" phenotype, we wondered whether *Gl* and *spri* genetically interact. As we expected, axon elongation and dendrite branching defects were observed *Gl^1^* PNs expressing *shRNA-spri* ([Fig. 3l--o](#F3){ref-type="fig"}, penetrance of extremely short axon in o: 38.9%, n= 7/18), suggesting that *strip, Gl* and *spri* cooperatively regulate axon elongation and dendrite branching.

Strip is involved in transporting early endosomes {#S5}
-------------------------------------------------

Since the main function of Gl is to regulate the initiation of dynein-based retrograde transport^[@R28],\ [@R29]^, it is possible that *strip^dogi^* mutation affects intracellular transport. Thus, to examine the function of Strip, we first analysed the subcellular localization of synaptotagmin, a representative axonal transport cargo regulated by the dynein-dynactin complex^[@R45]^. We expressed hemagglutinin (HA)-tagged synaptotagmin (syt-HA)^[@R46]^ in single-cell DL1 PN clones. Most of the syt-HA was delivered properly to the presynaptic sites in *strip^dogi^* PNs, but some of it accumulated abnormally in the axon stalks ([Supplementary Fig. 2h--j](#SD1){ref-type="supplementary-material"}, quantification in k). This accumulation was not observed in wild-type PNs ([Supplementary Fig. 2e--g](#SD1){ref-type="supplementary-material"}, quantification in k); thus, abnormal accumulation of syt-HA in *strip^dogi^* PN axon did not result from syt-HA overexpression. These data indicate that Strip is required for the intracellular transport of synaptic proteins in PN axons.

We also found defective subcellular localization of early endosomes in *strip^dogi^* PNs. Since the proper regulation of endosomal trafficking is required for neuronal morphogenesis^[@R6]^, we hypothesized that Strip affects the transport of early endosomes during axon elongation. When the early endosome marker, the green florescent protein (GFP)-fused FYVE domain (GFP-FYVE)^[@R47]^ was expressed in developing wild-type PNs, it was mainly localised at the termini but not in the stalk of axons at 21 hours after puparium formation ([Fig. 4a--c](#F4){ref-type="fig"}, quantification in g). Interestingly, GFP-FYVE showed significantly higher levels in the axon stalk of *strip^dogi^* PNs ([Fig. 4d--f](#F4){ref-type="fig"}, quantification in g) compared to that in the control ([Fig. 4a--c](#F4){ref-type="fig"}, quantification in g). Thus, Strip affects the subcellular localization of early endosomes in PN axons when axon elongation is taking place.

Strip and Gl are involved in clustering of early endosomes {#S6}
----------------------------------------------------------

To examine the effect of Strip on endosomal trafficking, the localization of Rab5- and Avalanche (Avl; *Drosophila* ortholog of Syntaxin 7, 12)^[@R48]^-positive early endosomes was examined in *Drosophila* S2 cells. The organisation of early endosomes consists of three steps; endocytosis, clustering, and fusion ([Fig. 5a](#F5){ref-type="fig"}). Retrograde transport is required for clustering of internalized vesicles (small early endosomes) that are formed by endocytosis^[@R18],[@R19]^. After clustering, small early endosomes undergo homotypic fusion to form mature early endosomes^[@R12],[@R13],[@R15]^. Interestingly, the size of Rab5- and Avl-positive early endosomes was significantly affected in S2 cells treated with *strip* dsRNA. Enlarged Rab5- and Avl-positive early endosomes were frequent in cells treated with control dsRNA ([Fig. 5b,e](#F5){ref-type="fig"}, Rab5 is quantified in 5h, and Avl is quantified in 5i), but they were smaller in cells treated with *strip* dsRNA ([Fig. 5c,f,h,i](#F5){ref-type="fig"}). Next, we tried to elucidate which step of early endosome orgnization is defective in *strip* knockdown. We examined the endocytosis ability of cells treated with *strip* dsRNA using the FM1-43 styryl dye and found that *strip* knockdown did not inhibit endocytosis ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}, see Methods for details). Furthermore, the same "smaller Rab5- and Avl-positive early endosomes" phenotype was observed when the cells were treated with *Gl* dsRNA ([Fig. 5d,g--i](#F5){ref-type="fig"}). These results suggest that Strip affects, at least, the clustering of early endosomes by forming a complex with Gl, which is consistent with the previous report that dynein-dependent early endosome transport from the periphery to the centre of a cell is required for the organization of early endosomes^[@R18],[@R19]^. We also revealed that Strip function in early endosome clustering is evolutionarily conserved. We treated HeLa cells with control or human *STRIP1* siRNA and stimulated them with fluorescent-labelled-EGF (EGF-Alexa488) for three minutes followed by washing to remove labelled EGF from the medium ([Fig. 6a](#F6){ref-type="fig"}). Like FM1-43 dye uptake assay performed in *Drosophila* S2 cells, endocytosis of EGFR bound to EGF-Alexa488 was not defective in *STRIP1* siRNA-treated HeLa cells, suggesting that STRIP1 knockdown does not inhibit endocytosis. EGF-Alexa488-positive vesicles were localized at cell periphery both in control or *STRIP1* siRNA-treated HeLa cells just after washing out the EGF-Alexa488 ([Fig. 6b,c](#F6){ref-type="fig"}). After thirty minutes incubation, the localization of EGF-Alexa488 was different between control and *STRIP1* siRNA-treated HeLa cells ([Fig. 6d--g](#F6){ref-type="fig"}, [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). In control cells, EGF-Alexa488-positive vesicles disappeared from cell periphery and mainly localized at peri-nuclear region ([Fig. 6d,e](#F6){ref-type="fig"}, quantified in h). On the other hand, in *STRIP1* siRNA-treated HeLa cells, most of cells possessed small and scattered EGF-Alexa488-positive vesicles, which are mainly at cell periphery ([Fig. 6f,g](#F6){ref-type="fig"}, quantified in h). In addition, those small EGF-Alexa488-positive vesicles are EEA1-negative ([Supplementary Fig. 4d--f](#SD1){ref-type="supplementary-material"} arrowheads), suggesting they are immature early endosomes. Thus, we concluded that *Drosophila* strip and human STRIP1 are involved in clustering of early endosome organization.

Strip regulates axon elongation by controlling Rab5 activity {#S7}
------------------------------------------------------------

Given that Strip makes complexes with Gl and Spri, we hypothesized that Strip affects the organization of early endosomes by properly clustering them with Gl and promoting early endosome fusion with Spri-Rab5, which are required for axon elongation. To confirm our hypothesis, we first investigated whether Rab5 is required for axon elongation in PNs by generating MARCM single-cell PN clones homozygous for a *Rab5* null mutation^[@R47]^ ([Fig. 7a](#F7){ref-type="fig"}). As in the *strip^dogi^* DL1 PN clones, the dendrites in *Rab5^2^* DL1 PN had additional branches appearing from the proximal side of the dendrite shaft, with a penetrance of 85.7% ([Fig. 7a](#F7){ref-type="fig"} arrowheads, n = 18/21). Some *Rab5^2^* DL1 dendrites targeted both DL1 and DL5, the same glomeruli targeted by the *strip^dogi^* DL1 PNs ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). In addition, *Rab5^2^* DL1 PNs had an extremely short axon phenotype (47.6%, n = 10/21), i.e., the axons stopped in the vicinity of the antennal lobe and did not extend toward the mushroom body or the lateral horn ([Fig. 7a](#F7){ref-type="fig"}, arrows). These phenotypes were similar to those observed in double mutant clones for *strip^dogi^* and *Gl^1^* ([Fig. 2m](#F2){ref-type="fig"}), *strip^dogi^* PNs expressing *shRNA-spri* ([Fig. 3k](#F3){ref-type="fig"}), or *Gl^1^* PNs expressing *shRNA-spri* ([Fig. 3o](#F3){ref-type="fig"}). The expression of yellow fluorescent protein (YFP)-fused Rab5 (YFP-Rab5)^[@R49]^ rescued *Rab5^2^* PNs phenotypes ([Fig. 7b,c](#F7){ref-type="fig"}), indicating that Rab5 is cell-autonomously required for dendrite branching and axon elongation in PNs.

Next, we examined the physical interactions among Strip, Spri, and Rab5. Since Spri is an ortholog of RIN-1 that exhibits Rab5-specific guanine nucleotide exchange activity^[@R43]^, one would expect that *Drosophila* Spri could have a higher affinity for GDP-bound forms of Rabs than for GTP-bound forms, which is the common feature of GEFs. As expected, c-myc-tagged Spri (Spri-myc) formed complex preferentially with a dominant-negative form of Rab5 (Rab5DN, Rab5S43N)^[@R49]^, which mimics the GDP-bound or free form of Rab5, and weakly to constitutively active form (Rab5CA, Rab5Q88L)^[@R49]^, which mimics the GTP-bound form ([Fig. 7d](#F7){ref-type="fig"}). In accordance with our hypothesis, Strip also had a higher affinity for GDP-bound forms of Rab5 than for GTP-bound forms ([Fig. 7d](#F7){ref-type="fig"}). In addition, we also confirmed the physical interaction between endogenous Strip and Rab5 ([Fig. 7e](#F7){ref-type="fig"}). Furthermore, we found that the level of Spri-myc was decreased when *strip* was knocked down in S2 cells ([Fig. 7f](#F7){ref-type="fig"}, quantification in g), indicating that Strip affects the protein level of Spri. Together, these results suggest that Strip is involved in Spri-mediated Rab5 activation by stabilizing Spri.

Since Strip seems to regulate the activity of Rab5 by forming a complex with Spri, we examined whether a constitutively active form of Rab5 (Rab5CA, Rab5Q88L) could compensate for the loss of Strip function in early endosomes during axon elongation. Indeed, the *strip^dogi^* short-axon phenotype ([Fig. 7i](#F7){ref-type="fig"}) was partially suppressed in *strip^dogi^* DL1 PN clones expressing Rab5CA ([Fig. 7j](#F7){ref-type="fig"}, quantification in l), with some axons even exhibiting L-shaped branching at the lateral horn ([Fig. 7j](#F7){ref-type="fig"}, white dotted circle). In contrast, the short-axon phenotype was enhanced in *strip^dogi^* DL1 PNs expressing a dominant-negative form of Rab5 (Rab5DN, Rab5S43N) ([Fig. 7k](#F7){ref-type="fig"}, quantification in l), i.e., most of axons were terminated at the calyx of the mushroom body ([Fig. 7l](#F7){ref-type="fig"} "class 3"). These data support our hypothesis that the Strip regulates axon elongation by controlling the activity of Rab5.

Discussion {#S8}
==========

During neural development, axon termini are exposed to a constantly changing surrounding environment. Thus, the spatio-temporal regulation of the amount of adhesion molecules and receptors at the axon growth cone is essential^[@R6]^. In this study, we identified uncharacterized protein Strip that forms complexes with Gl and Spri, and positively regulates clustering (retrograde transport along microtubule) of early endosomes. To form mature early endosomes from internalized small early endosomes, the coordination between clustering and fusion of early endosomes is crucial. For this, Strip serves as a molecular linker by interacting with Gl in clustering, and with Spri, Rab5 and probably with Vps45 in fusion. Vps45 is a Sec-1/Munc18 (SM) protein that targets Avl to promote fusion of early endosomes, which seems to function with Strip in the wing development (genetic interactions among *strip, Gl*, and regulators of early endosome fusion: [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Since we also observed genetic interaction between *spri* and *Gl* in axon elongation ([Fig. 3l,o](#F3){ref-type="fig"}), Strip seems to be a platform for early endosome organization by forming a dynein-Gl-Strip-Spri-Rab5 complex. Herein, we propose the following model to explain the physiological role of Strip in the organization of early endosomes ([Fig. 8](#F8){ref-type="fig"}, See [Fig. 8](#F8){ref-type="fig"} legend for details). During axon elongation, the strength of the elongation signal could be properly regulated by the dynein-Gl-Strip-Spri-Rab5 complex by affecting the organization of mature early endosomes. Mature early endosomes are essential vesicular structures for cell signalling, serving both as signalling centres and as sorting centres to degrade or recycle cargoes. In vertebrate neurons, target-derived nerve growth factor (NGF) mediates axon elongation via retrograde axon transport of TrkA-containing signalling endosomes locally or to the cell body to stimulate the expression of downstream target genes essential for long-term axon growth and target innervation^[@R7],[@R8]^. Furthermore, the amount of cell adhesion molecules might also be regulated by Strip-mediated early endosome organization. It has been reported that the regulation of the amount and localization of molecules such as L1 and integrin in the axon growth cone is essential for growth cone motility^[@R9]^.

Further investigations are still needed to identify which Strip domains are important for the formation of the dynein-Gl-Strip-Spri-Rab5 complex. Because Gl and Spri were identified using a yeast two-hybrid screen, it seems that the binding between Gl and Strip, and that between Spri and Strip are likely to be direct. Furthermore, we think that Gl and Spri bind to Strip simultaneously and form a tertiary complex for two reasons; 1) *Spri* and *Gl* showed genetic interaction in PNs and exhibited a phenotype similar to that of *stip^dogi^* PNs and 2) *Vps45* and *Gl* exhibited genetic interaction at the wing vein formation ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Thus, Strip seems to serve as a molecular linker between early endosome clustering and fusion by simultaneously forming a complex with Gl and Spri. Additionally, Strip seems to stabilize Spri protein level. Unfortunately, we were unable to produce a usable anti-Spri antibody; therefore we could not examine Spri localization. However, we speculate that Spri stabilized by Strip could determine the spatio-temporal localization and the activity of Rab5. Regarding the binding between Strip and Gl, we hypothesize that Strip may act as an adaptor between early endosomes and dynein. Unlike the highly diverse kines in superfamily proteins (KIFs), which encompass 45 genes, cytoplasmic dyneins have only two heavy chain family members in mammals^[@R3]^. Thus, adaptor proteins for the dynein motor are thought to be important to determine the cargo selectivity, and some adaptor proteins have already been reported^[@R3],[@R50],[@R51]^. Although Kif16b links Rab5 and microtubules^[@R52]^, no specific molecule linking the dynein heavy chain with Rab5-positive early endosomes has been reported yet. Therefore, we speculate that Strip could serve as an adaptor protein between Rab5-positive early endosomes and the dynein/dynactin complex by binding to Gl, similar to RILP and ORP1L that serve as adaptors between late endosomes and the dynein/dynactin complex^[@R50],[@R51]^.

We have provided genetic evidences that Strip, Gl, Spri, and Rab5 are required for both axon elongation and dendrite branching in PNs. However, the expression of a constitutively active form of Rab5 partially suppressed axon elongation and did not suppress dendrite branching defects of *strip^dogi^* PNs ([Fig. 7h--l](#F7){ref-type="fig"}, [Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}). We consider that the level and the spatio-temporal pattern of Rab5 activity are crucial. Axon elongation and dendrite branching may require different levels or patterns of Rab5 activity. Furthermore, the failure to suppress the dendrite phenotype could also be explained by the fact that not only formation, but also localization of mature early endosomes is required for dendrite branching. In *Drosophila* dendritic arborization (da) neurons, the proximal branching phenotype has been observed in the dendrite of *Rab5^2^, dynein light intermediate chain* (*dlic*), or the *kinesin heavy chain* (*khc*) mutant^[@R20]^. Consistent with this report, we also observed dendrite proximal branching phenotype in *Rab5^2^* or *strip^dogi^* PNs ([Fig. 2e,f](#F2){ref-type="fig"},[7a](#F7){ref-type="fig"}). The additional dendrite branched out from the dendrite stalk at a more proximal side in *Rab5^2^* or *strip^dogi^* PNs than in wild-type PNs. Therefore, we hypothesized that the constitutively active form of Rab5 could not suppress the dendrite phenotype in *strip^dogi^* PNs because the expression of the constitutively active form of Rab5 in *strip^dogi^* PNs could promote early endosome maturation in axon and dendrites, but could not adjust early endosome subcellular localization, which is crucial for dendrite branching.

Strip is structurally and functionally conserved. Branching and elongation defects in *strip^dogi^* PNs were rescued by the expression of the mouse homolog, Strip1 ([Fig. 1f,j,n](#F1){ref-type="fig"}). In addition, we also found that Strip1 is involved in neuronal migration in the mouse developing cerebral cortex ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}). In the mouse developing cerebral cortex, the Rab5-dependent endosomal trafficking pathway is required for neuronal migration^[@R53]^, rather than for neurite extension, probably because it occurs prior to dendrite formation and axon elongation *in vivo*. Electroporation of *Strip1* shRNA into the cerebral cortex at E14 caused migration defects ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}), similar to those observed when *Rab5* shRNAs were used^[@R53]^. Thus, *strip/Strip1* is involved in Rab5-dependent neural development including neuronal morphogenesis and migration events in both *Drosophila* and the mouse.

During our study of Strip function, Strip was reported as a member of the STRIPAK complex^[@R23],[@R24],[@R42]^. STRIPAK complex contains the PP2A phosphatase complex that is widely used as a phosphatase^[@R22]^. The core component of the PP2A phosphatase complex shows phosphatase activity, while the regulatory subunit determines the substrate specificity. Thus PP2A phosphatase targets specific molecules by changing the regulatory subunit. When Strip is included in the PP2A complex, Cka serves as a regulatory subunit and targets Hippo and probably RAF which belongs to the RAS-MAPK pathway^[@R23],[@R24]^. Since early endosome organization is important for many signal transduction pathways, it might be possible that axon elongation and dendrite targeting require both the dynein-Gl-Strip-Spri-Rab5 complex and the Strip-STRIPAK (Cka)-Hippo or the Strip-STRIPAK (Cka)-RAS-MAPK complex, but this does not seem possible, at least, in neuronal morphogenesis of PNs. When we generated PNs homozygous for *Cka*, we did not find any defects in axon elongation or dendrite branching ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). Thus, we think that the Strip-STRIPAK complex might not play a major role in neuronal morphogenesis.

The disruption of dynein or dynactin function causes neurodegeneration in many species, and this has been suggested to reflect impaired transport of signalling endosomes^[@R54]^. In humans, G59S and G59A missense mutations of p150^Glued^ have been discovered in motor neuropathy 7B^[@R55]^ and Perry syndrome^[@R56]^, respectively. Both mutations are located within the p150^Glued^ cytoskeleton-associated protein glycine-rich (CAP-Gly) domain, which is an MT-binding domain required for efficient retrograde transport. Progressive motor neuron degeneration is observed in *p150^Glued^* transgenic mice, with pathological similarities to amyotrophic lateral sclerosis (ALS), including muscle atrophy, axonal swelling, disrupted intracellular trafficking, and proliferation of degenerative organelles such as lysosomes and autophagosomes^[@R54],[@R57]^. Furthermore, motor neurons in Als2 (juvenile ALS-associated gene, Rab5GEF)-deficient mice show axonal degeneration. Moreover, the primary neurons in this mouse model, show disturbed endosomal trafficking of the insulin-like growth factor 1 (IGF-1) and brain-derived neurotrophic factor (BDNF) receptors^[@R54]^. These observations suggest that retrograde transport and Rab5GEF may play a particularly important role in axonal health by transmitting information about the local environment from the axon to the soma. Since Strip affects the early endosome organization by forming a complex with Gl and Spri, studying the functions of Strip may provide new insights into both developmental and pathological processes.

Methods {#S9}
=======

Genetic mapping of *strip^dogi^* mutants {#S10}
----------------------------------------

The causal gene, *strip* was mapped by single nucleotide polymorphism (SNP)-based recombination^[@R39]^, which showed that the mutation responsible for the projection neuron (PN) phenotype in the *strip^dogi^* MARCM clone was at a cytological location between 63A and 64A. Next, assuming that *strip^dogi^* is homozygous lethal, we performed a lethal complementation test with deficiency lines available for this candidate region. *Df(3L)HR232* and *Df(3L)HR119* failed to complement the *strip^dogi^* lethality, suggesting that the *strip^dogi^* chromosome maps within the genomic region from 63C02 to 63D02 (\~130 kb). We next measured the recombination rate from genetically mapped P-element insertion sites^[@R40]^. While generating recombinant lines, we obtained three independent recombinants that complemented the *strip^dogi^* lethality; analysis of their recombination points narrowed the candidate region down to \~28 kb. Next, we generated a small deficiency, *Df(tc-1)* (\~7 kb) ([Fig. 1o](#F1){ref-type="fig"}), using the *f05249* and *e04482 PiggyBac* lines. *Df(tc-1)* failed to complement the *strip^dogi^* lethality. Furthermore, we made *shRNA-strip* and PNs expressing *shRNA-strip* exhibited the phenotypes similar to those observed in *strip^dogi^* PN clones ([Supplementary Fig. 1d--f](#SD1){ref-type="supplementary-material"}). In addition, Strip protein expression was significantly reduced in *strip^dogi^* homozygous embryos ([Fig. 1p](#F1){ref-type="fig"}). Lastly, we confirmed that *UAS-strip* could mostly rescue the *strip^dogi^* PN clone phenotypes ([Fig. 1e,i,m](#F1){ref-type="fig"}), indicating that *strip* was the gene responsible for these phenotypes.

Clonal analysis {#S11}
---------------

We used the MARCM method^[@R58]^. Briefly, we crossed MARCM ready flies that contain *FLP* recombinase, an *FRT* site, *GAL4*, tublin 1 promoter-*GAL80* and *UAS-mCD8GFP/RFP* to a line containing the corresponding *FRT* and mutation of interest for MARCM analysis. To induce MARCM neuroblast clones, we heat-shocked (37 °C, 1h) flies with the appropriate genotype 0--24 h after larval hatching (ALH). To analyse DL1 PNs, we heat-shocked flies (37 °C, 1h) with the appropriate genotypes at 0--30h ALH for [Figure 1g, h, k, and l](#F1){ref-type="fig"}, or at 0--24h ALH for other analyses. The anterodorsal PN single-cell clones generated in this time period innervate the DL1 glomerulus. Dissections were performed on both genders of adults aged 1--10 days, with the exception of those described in [Fig. 4a--f](#F4){ref-type="fig"} (21 h after puparium formation, APF) and [Supplemetrary Fig. 1m--o](#SD1){ref-type="supplementary-material"} (0 h APF).

Fly strains {#S12}
-----------

The genotypes of *Drosophila melanogaster* used in each experiment are shown in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}. Flies were maintained under standard laboratory condition (25 °C). Both genders of adults aged 1--10 days are used for most studies. As for [Supplementary Figure 2a--d](#SD1){ref-type="supplementary-material"} and [Supplementary Figure 6](#SD1){ref-type="supplementary-material"}, adults aged 1--2 days were used. *Gl^1^, UAS-YFP-Rab5*^[@R49]^, *UAS-YFP-Rab5S43N*^[@R49]^, and *UAS-YFP-Rab5Q88L*^[@R49]^*, daughterless (da)-Gal4* were obtained from the Bloomington Stock Centre. *Rab5^2^* and *UAS-GFP-myc-2*x*FYVE* were kind gifts from Marcos González-Gaitán^[@R47]^, *UAS-syt-HA* is a kind gift from Thomas Schwarz^[@R46]^, *UAS-Vps45-RNAi, Vps45^JJ2^*, and *avl^1^* were kind gifts from David Bilder^[@R15],[@R59],[@R48]^, and *Cka^1^* is a kind gift from Steven X. Hou^[@R60]^.

DNA construction and generation of transgenic flies {#S13}
---------------------------------------------------

To generate *UAS-strip, UAS-strip-V5* and *UAS-FLAG-strip* flies, *strip* cDNA was amplified by PCR using the EST clone (AT25231) and was subcloned into *pUAST*. A V5 epitope tag was added at the *strip* C-terminus or a FLAG epitope tag was added at the *strip* N-terminus. The cDNA of *Mus musculus Strip1*, was amplified by PCR using the BC023952 EST clone. Since the 12bp of N-terminal sequence of this clone is reported not to align with the mouse genome, we corrected the sequence and subcloned it into *pUAST*. Transgenic flies were generated by BestGene Inc. The generation of *shRNA-strip, shRNA-Gl, shRNA-sprint*, and *UAS-resistant-strip* was designed as follows^[@R61]^. The two sites targeted by *shRNA-strip* were *shRNA-strip-6*: 5′-ATGGCTTGGAAACAGAAAAATA-3′ and *shRNA-strip-9*: 5′-CGGCCACAGCTACTGATATACT-3′; the two sites targeted by *shRNA-Gl* were *shRNA-Gl-1*: 5′-GCGAACTAATACCGGTATTATC-3′ and *shRNA-Gl-7*: 5′ -GGACCGACACAGAACTTTAAGA-3′; the two sites targeted by *shRNA-spri* were *shRNA-sprint-2*: 5′ -TTCAGCGGATTACTCATTAAGA-3′ and *shRNA-sprint-10*: 5′ -GCGGCCAGTAATCCCTTTAATG-3′. For *UAS-resistant-strip*, the 20th nucleotide of the *strip-shRNA-9* target site was altered from A to T. These shRNAs were subcloned into *pUAST* or *pUASTattB*, and transgenic flies were generated by BestGene Inc. To generate *UAS-spri-myc, sprint* cDNA was amplified by PCR using the EST clone (SD06366), and was subcloned in *pUAST*. A c-myc epitope tag was added at the C-terminus of *sprint*. To generate *shRNA-Strip1*, we used the Whitehead Institute's siRNA prediction tool to research target sites (<http://sirna.wi.mit.edu/>). We inserted oligonucleotides targeting four distinct regions in the *Strip1* coding sequence (*shRNA-Strip1-1*: 5′-GAATTCCTGATGAATCGAA-3′, *shRNA-Strip1-2*: 5′-CTATAAGGCTGACGACTCT-3′, *shRNA-Strip1-3*: 5′-GTTGAACCACATCTACCAG-3′, *shRNA-Strip1-4*: 5′-CGTACGGCAATGATCTTGA-3′) into the *pSilencer 3.0-H1 neo* vector (Ambion). All of these regions contained a hairpin loop sequence (5′-TTCAAGAGA-3′). To generate *pcDNA3-Strip1-V5*, we added a V5 epitope tag to the C-terminus of *Strip1* cDNA, and subcloned it into *pcDNA3.*

Detailed DNA constructions are available upon request.

Bioinformatics {#S14}
--------------

For homology searches, we used the In Paranoid: Eukaryotic Ortholog Groups (<http://inparanoid.sbc.su.se/cgi-bin/index.cgi>). Identity and similarity were calculated by the GENETYX-MAC. Clustal W (<http://clustalw.ddbj.nig.ac.jp/top-j.html>) was used to generate a phylogenetic tree of the *strip* homologs ([Supplementary Fig. 1k](#SD1){ref-type="supplementary-material"}).

Anti-Strip antibody generation {#S15}
------------------------------

We generated a recombinant protein representing a 91-amino-acid hydrophilic region of *Drosophila* Strip (amino acid 309 to 399 of PB, 264 to 354 of PA) in *E. coli* (*pCold* vector). The recombinant protein was purified and injected into rabbits or rats to generate polyclonal or monoclonal antibodies, respectively. The IgG fraction of the polyclonal antibody was purified. Antibody generation was performed by the Hokudo Co., Ltd.

Immunohistochemistry {#S16}
--------------------

The fixation and immunostaining of fly brains were carried out as follows^[@R62]^. Brains were dissected in 0.3% Triton X-100 (vol/vol) in phosphate-buffer (PBT), followed by fixing in 4% paraformaldehyde (PFA) (wt/vol) with 0.3% Triton X-100 (vol/vol) in PBT at RT for 20 min, and subsequently blocked in PBT with 5% normal goat serum (vol/vol) for 1 h at RT. Primary and secondary antibody incubation were carried out in PBST for overnight at 4 °C. For [Fig. 4a--f](#F4){ref-type="fig"}, pupal brains were dissected in cold Schneider's medium and incubated with primary antibody in Schneider's medium with 10% normal goat serum (vol/vol) at RT for 1 h, followed by quickly rinsing with cold PBS for 3 times and fixing in 4% PFA (vol/vol) in PBS at RT for 20 min. Subsequent blocking and antibody incubation were similar with adult brains. For *Drosophila* S2 cells, cells were cultured on Concanavalin A-coated coverslips, fixed, and immunostained as follows^[@R62]^. S2 cells were grown for 1 h at 26 °C on Concanavalin A-coated coverslips, and were fixed for 20 min in 4% PFA (wt/vol) with 0.3% Triton X-100 (vol/vol) in phosphate-buffer saline (PBST) at RT for 10 min, and subsequently blocked in PBST with 5% normal goat serum (vol/vol) for 30 min. Primary and secondary antibody incubation were carried out in blocking solution for 1 h at RT. For HeLa cells, cells were cultured on polyethylene-imine-coated cover slips, fixed, and immunostained as with the S2 cells. We used the following antibodies: nc82 (mouse, 1:40, DSHB), the anti-mCD8 (rat, 1:200, Invitrogen), anti-GFP (mouse, 1:1000, Clontech), the anti-DsRed (rabbit, 1:500, Clontech), anti-HA 12CA5 (mouse, 0.8 μg/ml, Roche), and anti-EEA1 (mouse, 1:500, BD Transduction Laboratories) antibodies. The anti-Rab5^[@R47]^ (rabbit, 1:1000) and the anti-Avl^[@R48]^ (rabbit, 1:200) antibodies are kind gifts from Marcos González-Gaitán, David Bilder and Thomas Vaccari. The anti-Strip (rat) was generated as described above (1:50).

Immunoprecipitation and immunoblotting {#S17}
--------------------------------------

S2 cell were sonicated in lysis buffer (25 mM Tris-HCl, pH 7.9, 10 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 10 mM DTT, and 1 × cOmplete (cocktail of protease inhibitors, Roche)) and incubated with anti-Strip antibody (rat, 1:100) or control IgG overnight. Protein G agarose (Roche) was added, and immunoprecipitation was performed according to the manufacturer's protocol. For the immunoprecipitation of c-myc tagged Sprint, S2 cells transfected with *Actin-Gal4 (pAcPa-Actin5c-Gal4), UAS-spri-myc* and *UAS-FLAG-strip* were lysed and incubated with EZ view Red Anti-c-Myc Affinity Gel (Sigma). For the immunoprecipitation of YFP tagged Rab5, *Rab5WT, Rab5CA, and Rab5DN* were subcloned in *pUAST* at first; *Rab5WT, Rab5CA, and Rab5DN* were amplified by PCR using *UAS-YFP-Rab5WT*^[@R49]^, *UAS-YFP-Rab5Q88L*^[@R49]^, and *UAS-YRP-Rab5S43N*^[@R49]^ flies as template. S2 cells transfected with *Actin-Gal4, UAS-spri-myc* and *UAS-YFP-Rab5 WT/CA/DN* were lysed and incubated with anti-GFP antibody (rabbit, 1:500, MBL) overnight. Protein G agarose (Roche) was added and immunoprecipitation was performed according to the manufacturer's protocol. Western blotting was performed according to standard techniques. Briefly, we subjected 2--10 μg of S2 cell lysates or embryo lysates to SDS-PAGE analysis (12.5% for Histon H3 and Rab5 detection; for others, 7.5% or 10%) and immunoblotting. The following antibodies were used for immunoblotting: the anti-Strip antibody (rabbit, 1:200), the anti-Strip antibody (rat, 1:50), the anti-α-tubulin (mouse, 1:2000, Sigma), the anti-Gl C-term antibody^[@R27]^ (rabbit, 1:2000), the anti-GFP antibody (mouse, 1:2000, Roche), anti-myc antibody (mouse, 1:1000, Invitrogen), anti-FLAG antibody (mouse, 1:1000, Sigma), anti-V5 antibody (mouse, 1:200, Invitrogen), anti-GST (mouse, 1:200, Santa Cruz Biotechnology), and the anti-Histone H3 antibody (rabbit, 1:2000, Active motif). The anti-Rab5 antibody^[@R47]^ (rabbit, 1:1000) is a kind gift from M. González-Gaitán. All data are representative of more than three biological replicates. Images of the full blots for all western blots are provided in [Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}.

GST pull-down {#S18}
-------------

The Gl fragment from 676 to 914 amino acids was amplified from genomic DNA and the Spri fragment from 1404 to1700 amino acids were amplified by PCR using EST clone (SD06366). Both of these fragments were subcloned into *pGEX-5X3*. GST, GST-Gl (676-914 a.a.), or GST-Spri (1404-1700 a.a.) was expressed in BL21 (DE3) bacterial cells and purified with Glutathione Sepharose 4 Fast Flow (GE). These glutathione sepharose beads were co-incubated with embryo lysates (*UAS-strip-V5/+; daughterless (da)-Gal4/+* or *da-Gal4/UAS-FLAG-strip*) collected at 0-22 h after egg laying.

Yeast two-hybrid screening {#S19}
--------------------------

For yeast two-hybrid screening, the full length of *strip* was used as bait and the *Drosophila* whole-embryo library was used as prey; the screening was performed by the Hybrigenics.

dsRNA generation and treatment {#S20}
------------------------------

The dsRNA design, production, and treatment were performed as follows^[@R63]^. 700-900 bp gene-specific sequences with T7 RNA polymerase sequence at both ends were amplified by PCR and *in vitro* transcription was performed using T7 RiboMAX Express RNAi System (Promega) according to the manufacturer's protocol. For *strip* dsRNA, templates for *in vitro* transcription were generated using the primers 5′-TAATACGACTCACTATAGGGCCTGCATAAACCTGCTGCGC-3′ and 5′-TAATACGACTCACTATAGGGCTAGAGGGCGTCCCAGTCGG-3′. For control and *Gl* dsRNA, primer sequences were used to amplify the sequence from the bacterial cloning plasmid pBluescript SK^[@R63]^ and the *Gl* C-terminus^[@R27]^. Cells (1.0 × 10^6^) were cultured in a 35-mm dish; 30 μg dsRNA was applied every two days until the cells were used for analysis. For [Figure 5](#F5){ref-type="fig"}, cells were treated with control, *strip*, or *Gl* dsRNA for 8 days. For [Figure 7f](#F7){ref-type="fig"}, S2 cells that stably express YFP-Rab5 were transfected with *Actin-Gal4* and *UAS-sprint-myc* for two days and split into half to treat with control or *strip* dsRNA for 6 days.

Transfection with shRNA {#S21}
-----------------------

*Actin-Gal4* and desired UAS construct (UAS-shRNA-strip, UAS-FLAG-strip, UAS-spri-myc, UAS-YFP-Rab5WT, DN, or CA) were co-transfected using Effectene Transfection Reagent (Qiagen); 2.0×10^6^ *Drosophila* S2 cells for 35-mm dish, 6.0×10^6^ cells for 60-mm dish were plated and transfection was performed according to the manufacturer's protocol. Cells were collected for immunoblots 48 h after transfection. *pcDNA3-Strip1-V5* and *shRNA-Strip1-1, 2, 3 or 4* were co-transfected using Lipofectamin 2000 (Invitrogen); 1.0 × 10^5^ HEK293T cells were plated on a 35-mm dish, and transfection was performed according to the manufacturer's protocol. Cells were collected for immunoblots 24 h after transfection.

FM1-43 dye assay {#S22}
----------------

*Drosophila* S2 cells were plated on Concanavalin A-coated cover slips, and treated with 5 μg/ml FM1-43 dye (Molecular Probes)/ HBSS for 1 min, and incubated for 5 min at 25 °C after a quick wash, and fixed immediately with 4% (vol/vol) PFA/HBSS without washing. Fixation was 10 min at RT. Cells were mounted with SlowFade® Gold antifade reagent with DAPI (Invitrogen).

EGF-Alexa488 uptake assay in HeLa cells {#S23}
---------------------------------------

Dharmacon siGENOME non-Targeting siRNA Pool \#1 (D-00126-13-05) (100 nM) or siGENOME SMARTpoll human STRIP1 (M-02516091-005) (100 nM) was transfected into HeLa cells (1.0 × 10^5^) with Lipofectamin 2000 (Invitrogen) according to manufacturer's protocol, cultured for 3 days, and plated on polyethylene-imine-coated cover slips for over night. Cells were pulsed with Alexa Fluor 488 EGF complex (Invitrogen) for 3 min and immediately fixed or rinsed and incubated for 27 min at 37 °C and fixed.

Electroporation *in utero* {#S24}
--------------------------

Animals were handled according to the guidelines established by the University of Tokyo and Keio University. All the electroporations were performed on E14 embryos. Electroporation *in utero* and the measurement of EGFP fluorescence intensity in various regions of the cerebral cortex were performed as follows^[@R53]^. Fluorescent images of frozen section of EGFP expressing mouse brains were captured by TCS-SP5 laser scanning confocal microscopy (Leica). Fluorescence intensities inside similar width rectangles in various regions of the cerebral cortex (layers II--IV, V--VI, IZ, and SVZ/VZ) were measured by the Leica SP5 software. Relative intensities to the total fluorescence were calculated and plotted in the graphs with standard errors.

Image acquisition {#S25}
-----------------

For all experiments other than HeLa cell imaging, images were obtained using TCS-SP5 laser scanning confocal microscopy (Leica) with a PL APO CS 40×/1.25 Oil lens (Leica) for PN imaging or a PL APO CS 63×/1.40 Oil lens (Leica) for imaging of S2 cells. For imaging of HeLa cells, TCS-SP8 laser scanning confocal microscopy (Leica) with a PL APO CS 63×/1.40 Oil lens was used. Fields of view were randomly selected and all experiments were repeated more than three times. For PN clones other than [Figure 4](#F4){ref-type="fig"}, more than 10 clones were imaged and representative images were shown in Figures. For PN clones of [Figure 4](#F4){ref-type="fig"}, S2 cells and HeLa cells, the exact number of samples imaged was shown in each Figure.

Image analysis {#S26}
--------------

For [Figure 4](#F4){ref-type="fig"}, fluorescence intensities of FYVE-GFP and mCD8RFP inside axon stalks (200 μm^2^) were measured by the Leica SP5 software. For [Figure 5](#F5){ref-type="fig"}, image analysis was performed using the Particle Analyzer of ImageJ software. Single section that passes the centre of cells was selected for each S2 cell stained with the anti-Rab5 antibody or the anti-Avl antibody, and the size of vesicles was determined by using the particle analyzer. For [Figure 6](#F6){ref-type="fig"}, [Figure 7l](#F7){ref-type="fig"}, and [Supplementary Figure 2k](#SD1){ref-type="supplementary-material"}, all images were blinded prior to the classification to avoid experimental bias. The investigator who conducted the blind test was totally independent from the investigator who performed experiments.

Statistical analysis {#S27}
--------------------

Statistical analysis was performed using Prism software (GraphPad). Unpaired two-tailed *t*-tests were used to compare the GFP-FYVE intensity between control and *strip* PNs, and for the quantitative analysis of the extent of cell migration in the mice cerebral cortex. The chi-square test was used to compare data variations among control, *strip*, or *Gl* dsRNA-treated S2 cells or between control and *STRIP1* siRNA-treated HeLa cells. The chi-squre test was also used to compare data variations of synaptotagmin localization between control or *strip^dogi^* PNs. Exact P-values are provided unless p \< 0.0001.
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![Branching and elongation defects of *strip^dogi^* homozygous projection neurons.\
(a) Schematic view of projection neurons (PNs). Olfactory information is transmitted from the olfactory receptor neurons (light green) to PNs (dark green) at the antennal lobe (AL, pink circle). The dendrite of a single PN targets a specific glomerulus out of 50 glomeruli in the AL, while the axon elongates and branches at the mushroom body (MB) and the lateral horn (LH). (b) Representative image of wild-type (WT) DL1 mosaic analysis with a repressible cell marker (MARCM) clone, DL1 PN (green). Magenta: Bruchpilot staining. Asterisk: cell body. Yellow and white dotted circles indicate MB and the LH, respectively. (c--f) Representative images of WT (c), *strip^dogi^* neuroblast clones (d), *strip^dogi^* neuroblast clones expressing cDNA of *strip* (e) or cDNA of mouse homolog of *strip, Strip1* (f). Contralateral ALs are marked by dotted circles and neurite innervation to subesophageal ganglion (SOG) is indicated by an arrowhead (d). (g--n) Representative images of DL1 MARCM single-cell clone of each genotype. (g--j) Dendrites of DL1 PNs. DL1 and DL5 glomeruli are indicated by dotted circles and cell bodies are labelled with asterisks. (k--n) Axons of DL1 PNs. Yellow and white dotted circles indicate the mushroom body (MB) and the lateral horn (LH), respectively. Scale bar: 25 μm. (o) Genomic structure of *strip*. The small deletion allele *Df(tc-1)* lacks 7 kb of the genomic region containing *strip, CG42456, CG12016, and CG12077*. Scale bar: 5 kbp. (p) Strip expression in WT, the zygotic mutant homozygous for *strip^dogi^* or *Df(tc-1)*. Embryo lysates from 18--21 h after egg-laying (AEL) were used for immunoblotting; Strip protein was detected by the anti-Strip antibody. The Strip protein is about 130 kDa.](nihms-626466-f0001){#F1}

![Glued (Gl) physically and genetically interacts with Strip\
(a) Comparison between *Drosophila* Gl and its mouse orthologue, p150^Glued^. The 680--914 amino-acid region of Gl bound strongly to Strip in a yeast two-hybrid screen. This is analogous to the 651--876 amino acid region of p150^Glued^ (68.9% similarity and 23.0% identity); this region interacts with the dynein motor protein and the Arp1 rod. (b) Lysates of 0--22 h after egg-laying (AEL) embryos that express Strip-V5 were pulled down with GST-fused Gl domain that binds to Strip in the yeast two-hybrid screen. (c) Immunoprecipitation of S2 lysates. Endogenous Gl was co-immunoprecipitated when endogenous Strip was precipitated by the anti-Strip antibody. (d--m) Genetic interactions between *strip* and *Gl* in projection neurons (PNs). MARCM DL1 single-cell clones for *strip^dogi^* (d--f), *Gl^1^*(g--i), or both *strip^dogi^* and *Gl^1^* (j--m) were generated at 0--24 h ALH (green). Magenta: Bruchpilot staining. Scale bar: 25 μm. (d,g,j) Axons. Yellow and white dotted circles indicate the mushroom body (MB) and the lateral horn (LH), respectively. (e,f,h,i,k,l) Dendrites. Cell bodies are indicated by asterisks. (f), (i), and (l) are magnified images of dotted rectangles of (e), (h), and (k), respectively. Only green channels are shown in grey scale. DL1 glomeruli are labelled with dotted red circles. Additional dendrite branches are indicated by arrowheads. (m) Representative image of *strip^dogi^* and *Gl^1^* DL1 PN exhibiting the "extremely short axon" phenotype; the axon did not exit the antennal lobe (AL, white circle) and did not enter the mushroom body (MB, yellow dotted circle) or the lateral horn (LH, white dotted circle).](nihms-626466-f0002){#F2}

![Sprint (Spri) physically and genetically interacts with Strip\
(a) Comparison between *Drosophila* Spri and its human orthologue, RIN-1. The 1404--1700 amino-acid region of Spri bound strongly to Strip in a yeast two-hybrid screen. This is analogous to the vacuolar protein sorting homology domain 9 (VPS9) that is required for guanine nucleotide exchange activity. SH2: Src homology domain 2, RA: Ras association domain. (b) Lysates of 0--22 h after egg-laying (AEL) embryos expressing FLAG-tagged Strip (FLAG-Strip) was pulled down with GST-fused Spri (Strip binding domain). (c, d) Immunoprecipitation of S2 lysates expressing c-myc tagged Spri (Spri-myc) and FLAG-Strip. Spri-myc was co-immunoprecipitated when FLAG-Strip was precipitated by the anti-Strip antibody (c). FLAG-Strip was co-immunoprecipitated when Spri-myc was precipitated by the anti-c-myc antibody. Since FLAG-Strip was detected with the anti-Strip antibody, the lower band represents endogenous Strip (d). (e--o) Genetic interactions between *spri* and *strip or spri and Gl* in projection neurons (PNs). MARCM DL1 single-cell clones expressing *shRNA-spri* (e--g), *strip^dogi^* DL1 single-cell clones expressing *shRNA-spri* (h--k), or *Gl^1^* DL1 single-cell clones expressing *shRNA-spri* (l--o) were induced (green) at 0--24 h ALH. Magenta: Bruchpilot staining. Scale bar: 25 μm. (e,h,l) Axons. Yellow and white dotted circles indicate the mushroom body (MB) and the lateral horn (LH), respectively. (f,g,i,j,m,n) Dendrites. Cell bodies are indicated by asterisks. (g), (j), and (n) are magnified images of dotted rectangles of (f), (i), and (m), respectively. Only green channels are shown in grey scale. DL1 glomeruli are labelled with dotted red circles. Additional dendrite branches are indicated by arrowheads. (k.o) representative images of *strip^dogi^* DL1 PNs expressing the *shRNA-spri* (k), and *Gl^1^* DL1 PNs expressing the *shRNA-spri* (o) exhibiting the "extremely short axon" phenotype, i.e., the axon did not exit the antennal lobe (white circle) and did not enter the mushroom body (MB, yellow dotted circle) or the lateral horn (LH, white dotted circle).](nihms-626466-f0003){#F3}

![Localization of early endosomes was altered in the axons of developing *strip* projection neurons (PNs)\
(a--f) A GFP-fused FYVE domain (GFP-FYVE) was expressed in PNs, and its localization was investigated at 21 h after puparium formation (APF). Axons of wild-type (WT, a--c) and *strip^dogi^* PNs (d--f). (a, d) GFP-FYVE and MARCM neuroblast clones labelled by mCD8-RFP are shown in green and magenta, respectively. (b,e) Only green channels are shown in grey scale. (c) and (f) are magnified images of dotted rectangles of (b) and (e), respectively. Scale bar: 25 μm. (g) The intensity of GFP-FYVE in the axon stalk (200 μm^2^) was normalized to the intensity of mCD8RFP and then plotted. Error bars are defined as SEM. \*\*p = 0.0047, *t*-test.](nihms-626466-f0004){#F4}

![Localization defects of early endosomes in *strip* knockdown *Drosophila* S2 cells\
(a) Schematic view of endocytic pathways. Early endosome organization consists of three steps, endocytosis, clustering and fusion of small early endosomes. (b--g) Localization of early endosome markers (Rab5 and Avalanche, Avl) in the control (b,e), *strip* (c,f), and *Gl* (d,g) dsRNA-treated S2 cells. (b--d) Rab5-positive early endosomes. (e--g) Avl-positive early endosomes. Scale bar: 7.5 μm. (h,i) Quantification of the size of Rab5-positive early endosomes (h) and Avl-positive early endosomes (i). The area of each vesicle was measured with the Particle Analyzer of the ImageJ software. The percentage of cells whose largest vesicle with sizes \>1 μm^2^, \>0.5 μm^2^ but \<1 μm^2^, and \<0.5 μm^2^ are shown. \*p = 0.049, \*\*p = 0.0068, \*\*\*p \< 0.0001, chi-square test.](nihms-626466-f0005){#F5}

![Localization defects of EGF-Alexa488 in *STRIP1* knockdown HeLa cells\
(a) Summary of EGF-Alexa488 uptake assay. (b--g) Localization of EGF-Alexa488 in the control (b,d,e) and *STRIP1* (c,f,g) siRNA-treated HeLa cells. HeLa cells were transfected with control or *STRIP1* siRNA for 3 days, and endocytosis uptake was assayed with EGF-Alexa488. After a 3 min uptake of EGF-Alexa488, cells were fixed (b,c) or washed with DMEM and cultured for 27 min and fixed (d--g). The rectangle regions of (d) and (f) are magnified at (e) and (g), respectively. Scale bar: 10 μm. (h) All cells were classified into having or not having EGF-Alexa488 at cell periphery by a blind test. \*\*\*p\<0.0001, chi-square test.](nihms-626466-f0006){#F6}

![Strip affects Rab5 activity in axon elongation\
(a--c) Representative image of *Rab5^2^* DL1 PNs (a, green) and *Rab5^2^* DL1 PNs expressing YFP fused Rab5 (b,c, green). Magenta: Bruchpilot staining. Asterisk: Cell body. Yellow and white dotted circles indicate the mushroom body (MB) and the lateral horn (LH), respectively. Scale bar: 25 μm. (d) Immunoprecipitation of S2 lysates expressing c-myc tagged Spri (Spri-myc) and YFP-tagged Rab5 (YFP-Rab5WT), YFP-tagged dominant negative form of Rab5 (YFP-Rab5DN) or YFP-tagged constitutively active form of Rab5 (YFP-Rab5CA). Spri-myc and Strip were co-immunoprecipitated when YFP-Rab5 WT/CA/DN were precipitated by the anti-GFP antibody. (e) Immunoprecipitation of S2 lysates. The anti-Strip antibody co-immunoprecipitated Strip and endogenous Rab5. (f) The expression level of Spri-myc in control and *strip* dsRNA-treated S2 cells. Knockdown efficiency was confirmed by anti-Strip antibody and anti-Histone H3 was used as a loading control. (g) Densitometric analysis of Spri-myc in (f). The intensity of Spri-myc was measured by using Image J software and normalized against the intensity of Histone H3 and showed in graph. (h--k) Representative image of DL1 wild-type (WT, h), *strip^dogi^* PN (i), *strip^dogi^* PN expressing constitutively active form of Rab5 (Rab5CA, Rab5Q88L, j), and *strip^dogi^* PN expressing dominant-negative form of Rab5 (Rab5DN, Rab5S43N, k) labelled by mCD8RFP (green). Magenta: Bruchpilot staining. Yellow and white dotted circles indicate the mushroom body (MB) and the lateral horn (LH), respectively. Scale bar: 25 μm. (l) The axons of DL1 PNs were categorized into three classes according to the extent of elongation in a blind test. Class 1 axons reached the end of the LH, while class 3 axons terminated near the mushroom body (l, arrowheads). The percentage of PNs in each category is shown in (l).](nihms-626466-f0007){#F7}

![Hypothetical model for the function of Strip in axon elongation.\
Strip (red) binds to the dynein accessory proteins Glued (green) and Sprint (purple), and forms a complex with the Rab5 (blue)-containing early endosomes, suggesting that Strip seems to be in a large molecular complex, dynein-Gl-Strip-Spri-Rab5 complex (see the dotted rectangle). Thus, Strip seems to serve as a molecular linker of clustering and fusion steps of internalized small early endosomes, which is essential for the organization of mature early endosomes containing a ligand-receptor complex analogous to the vertebrate neurotrophin-TrkA complex that sends signals for axon growth.](nihms-626466-f0008){#F8}
